0001209191-18-058384.txt : 20181113 0001209191-18-058384.hdr.sgml : 20181113 20181113182940 ACCESSION NUMBER: 0001209191-18-058384 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181108 FILED AS OF DATE: 20181113 DATE AS OF CHANGE: 20181113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vaughn James J CENTRAL INDEX KEY: 0001649689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 181179751 MAIL ADDRESS: STREET 1: C/O GENOMIC HEALTH, INC. STREET 2: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-08 0 0001131324 GENOMIC HEALTH INC GHDX 0001649689 Vaughn James J 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063 0 1 0 0 Chief Commercial Officer Common Stock 2018-11-08 4 M 0 3000 31.12 A 20542 D Common Stock 2018-11-08 4 S 0 1100 83.9391 D 19442 D Common Stock 2018-11-08 4 S 0 1300 85.1846 D 18142 D Common Stock 2018-11-08 4 S 0 300 85.84 D 17842 D Common Stock 2018-11-08 4 S 0 300 89.0667 D 17542 D Employee Stock Option (right to buy) Holding 31.12 2018-11-08 4 M 0 3000 0.00 D 2025-02-13 Common Stock 3000 36772 D Includes an aggregate of 15,534 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 6, 2018. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $83.66 to $84.20. Represents weighted average sale price. Actual sale prices ranged from $84.66 to $85.64. Represents weighted average sale price. Actual sale prices ranged from $85.77 to $85.90. Represents weighted average sale price. Actual sale prices ranged from $88.88 to $89.42. The option became exercisable as to 25% of the shares on February 13, 2016, and becomes exercisable as to 1/48th of the shares each full month thereafter. /s/ Jason W. Radford, Attorney-in-fact 2018-11-13